ConductScience.org, home

Paper42717153

Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.

Lipton RB and 10 others. Neurol Ther, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE. Papers, record 42717153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42717153

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.
PubMed
Journal
Neurol Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-10
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06467370A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.Derived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139661241The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region.Pain Ther2025https://conductscience.org/library/papers/39661241PubMed
239262214International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine.Cephalalgia2024https://conductscience.org/library/papers/39262214PubMed
334160823The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.Headache2021https://conductscience.org/library/papers/34160823PubMed
438466028Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update.Headache2024https://conductscience.org/library/papers/38466028PubMed
540663598Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns.Headache2025https://conductscience.org/library/papers/40663598PubMed
639404951What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle.Neurol Ther2024https://conductscience.org/library/papers/39404951PubMed
741721442Unmet treatment needs in migraine: Results of the OVERCOME (US) study.Headache2026https://conductscience.org/library/papers/41721442PubMed
840238598Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment.Pain Manag2025https://conductscience.org/library/papers/40238598PubMed
926252585Preventive Migraine Treatment.Continuum (Minneap Minn)2015https://conductscience.org/library/papers/26252585PubMed
1037208596The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.J Headache Pain2023https://conductscience.org/library/papers/37208596PubMed
1135027572Migraine.Nat Rev Dis Primers2022https://conductscience.org/library/papers/35027572PubMed
1231020659Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.Headache2019https://conductscience.org/library/papers/31020659PubMed
1342288801Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial.J Headache Pain2026https://conductscience.org/library/papers/42288801PubMed
1439762740Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study).J Headache Pain2025https://conductscience.org/library/papers/39762740PubMed
1539333875First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients.J Headache Pain2024https://conductscience.org/library/papers/39333875PubMed
1641204073Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study.J Headache Pain2025https://conductscience.org/library/papers/41204073PubMed
1739766367Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study.Brain Sci2024https://conductscience.org/library/papers/39766367PubMed
1817062301
Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Clin Ther2006https://conductscience.org/library/papers/17062301PubMed
1920869152Controlled phase III clinical trial of diclofenac potassium liquid-filled soft gelatin capsule for treatment of postoperative dental pain.J Oral Maxillofac Surg2010https://conductscience.org/library/papers/20869152PubMed
2024631409Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort.Eur Urol2015https://conductscience.org/library/papers/24631409PubMed

See all 42 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42717153

GET https://conductscience.org/api/papers/v1/42717153/references?page=2